Financials Enablence Technologies Inc.
Equities
ENA
CA2924833023
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7 CAD | 0.00% | 0.00% | -51.72% |
Valuation
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 18.7 | 9.802 | 7.172 | 7.172 | 25.94 | 23.55 |
Enterprise Value (EV) 1 | 32.03 | 30.89 | 35.18 | 42.22 | 31.73 | 31.91 |
P/E ratio | -1.8 x | -1 x | -0.75 x | -1.12 x | 1.6 x | -2.74 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 5.52 x | 6.88 x | 6.51 x | 2.84 x | 13.1 x | 12 x |
EV / Revenue | 9.45 x | 21.7 x | 32 x | 16.7 x | 16 x | 16.3 x |
EV / EBITDA | -4.11 x | -4.06 x | -5.58 x | -10.2 x | -5.62 x | -4.17 x |
EV / FCF | -5.4 x | -6.27 x | -7.1 x | -11.3 x | -7.62 x | -7.41 x |
FCF Yield | -18.5% | -16% | -14.1% | -8.82% | -13.1% | -13.5% |
Price to Book | -1.32 x | -0.42 x | -0.23 x | -0.18 x | -2.65 x | -1.82 x |
Nbr of stocks (in thousands) | 5,183 | 5,349 | 5,349 | 5,349 | 18,590 | 18,590 |
Reference price 2 | 3.608 | 1.832 | 1.341 | 1.341 | 1.395 | 1.267 |
Announcement Date | 10/29/18 | 10/28/19 | 5/12/21 | 10/21/21 | 10/28/22 | 11/1/23 |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 3.388 | 1.424 | 1.101 | 2.521 | 1.978 | 1.961 |
EBITDA 1 | -7.786 | -7.613 | -6.31 | -4.145 | -5.644 | -7.644 |
EBIT 1 | -8.512 | -7.92 | -6.462 | -4.296 | -5.784 | -7.842 |
Operating Margin | -251.24% | -556.18% | -586.92% | -170.41% | -292.42% | -399.9% |
Earnings before Tax (EBT) 1 | -10.38 | -9.78 | -9.557 | -5.041 | 11.49 | -9.59 |
Net income 1 | -10.38 | -9.78 | -9.557 | -5.041 | 11.69 | -8.605 |
Net margin | -306.29% | -686.8% | -868.03% | -199.96% | 591.15% | -438.81% |
EPS 2 | -2.002 | -1.833 | -1.787 | -1.200 | 0.8700 | -0.4629 |
Free Cash Flow 1 | -5.93 | -4.928 | -4.954 | -3.726 | -4.162 | -4.305 |
FCF margin | -175.03% | -346.09% | -449.99% | -147.78% | -210.41% | -219.51% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 10/29/18 | 10/28/19 | 5/12/21 | 10/21/21 | 10/28/22 | 11/1/23 |
Balance Sheet Analysis
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 13.3 | 21.1 | 28 | 35 | 5.79 | 8.36 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | -1.713 x | -2.77 x | -4.439 x | -8.455 x | -1.026 x | -1.093 x |
Free Cash Flow 1 | -5.93 | -4.93 | -4.95 | -3.73 | -4.16 | -4.3 |
ROE (net income / shareholders' equity) | 112% | 52.1% | 34.2% | 14.1% | -47.2% | 75.8% |
ROA (Net income/ Total Assets) | -77.3% | -157% | -223% | -179% | -256% | -132% |
Assets 1 | 13.43 | 6.239 | 4.283 | 2.822 | -4.569 | 6.5 |
Book Value Per Share 2 | -2.730 | -4.370 | -5.960 | -7.430 | -0.5300 | -0.6900 |
Cash Flow per Share 2 | 0.0200 | 0.0100 | 0.0300 | 0.0400 | 0.0100 | 0.2300 |
Capex 1 | 0.39 | 0.18 | 0.19 | 0.06 | 0.11 | 0.52 |
Capex / Sales | 11.36% | 12.85% | 17.08% | 2.54% | 5.61% | 26.26% |
Announcement Date | 10/29/18 | 10/28/19 | 5/12/21 | 10/21/21 | 10/28/22 | 11/1/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-51.72% | 9.62M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- ENA Stock
- Financials Enablence Technologies Inc.